SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTION LTE LONG-TERM EXTENSION STUDY

Stefan Schreiber  1     Mamoru Watanabe  2     Ulrik Moerch  3     Gerhard Rogler  4     Edward V Loftus Jr  5     Jeremy Hsieh  6     Yan Zhou  7     Sally Zhao     Chohee Yun    
1 University Hospital Schleswig-Holstein,Kiel,Germany
2 Tokyo Medical and Dental University,Tokyo,Japan
3 Gilead Sciences, Inc.,Copenhagen,Denmark
4 University of Zurich,Zurich,Switzerland
5 Mayo Clinic College of Medicine,Rochester, Minnesota,United States
6 Gilead Sciences, Inc.,Foster City,United States
7 Gilead Sciences, Inc.,Foster City

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing